Insiders have been buying these ASX shares

At the end of each week I like to look at which ASX shares have been experiencing notable insider buying. This is because I believe insider buying can be a bullish indicator as few people ought to know a company, its industry, prospects, and true value better than its own directors.

Three shares which have reported meaningful insider buying this week are listed below:

Monash IVF Group Ltd (ASX: MVF)

According to a change of director’s interest notice, independent non-executive director Christina Boyce has picked up 40,000 shares in the embattled fertility treatment company for a total consideration of $37,500 through two on-market trades. This equates to an average price of 97.8 cents per share. Unfortunately for the director the market selloff has dragged Monash IVF’s shares down to a 52-week low of 92 cents today.

Myer Holdings Ltd (ASX: MYR)

A change of director’s interest notice out of this department store operator reveals that its independent non-executive director, David Whittle, has been buying its shares on-market this week. Mr Whittle picked up 54,321 shares for a total consideration of $27,975.32. This works out to be an average price of 51.5 cents per share. Fellow director Margaret Cattermole was also buying shares this week. She snapped up almost $50,000 worth of shares on Tuesday. This could be a sign that the Myer board is confident in its turnaround plans.

Resolute Mining Limited (ASX: RSG)

This gold miner’s CEO, John Welborn, bought 52,412 shares for a total consideration of approximately $55,000 this week. The gold miner’s shares have fallen heavily since the end of August and Mr Welborn appears to believe that they have fallen down to an attractive level now. This brought the CEO’s holding up to a total of 4.5 million fully paid ordinary shares. He also has various performance rights that may be vested in the future.

The number #1 dividend share on the ASX today

You might not know this market leader's name, but it's rapidly expanding into a highly profitable niche market here in Australia. Even better, the shares boast a strong, fully franked dividend that should balloon in the years to come. In other words, we're looking at the holy grail of incredible long-term growth potential AND income you can watch accruing in your account in real time!

Simply click here to grab your FREE copy of this up-to-the-minute research report on our #1 dividend share recommendation now.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Monash IVF Group Ltd. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

Two New Stock Picks Every Month!

Not to alarm you, but you’re about to miss a very important event! Chief Investment Advisor Scott Phillips and his team at Motley Fool Share Advisor are about to reveal their latest official stock recommendation. The premium “buy alert” will be unveiled to members and you can be among the first to act on the tip.

Don’t let this opportunity pass you by – this is your chance to get in early!

Simply enter your email now to find out how you can get instant access.

By clicking this button, you agree to our Terms of Service and Privacy Policy. We will use your email address only to keep you informed about updates to our website and about other products and services we think might interest you. You can unsubscribe from Take Stock at anytime. Please refer to our Financial Services Guide (FSG) for more information.